Management of travellers' diarrhoea

BMJ

Volumn 337, Issue 7674, 2008, Pages 863-867

  Hill, David R ^a   Ryan, Edward T ^b  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH SALICYLATE; CHOLERA VACCINE; CIPROFLOXACIN; DOXYCYCLINE; LEVOFLOXACIN; LOPERAMIDE; NORFLOXACIN; OFLOXACIN; PLACEBO; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; SALICYLIC ACID DERIVATIVE; WARFARIN;

ARTHROPATHY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTERIACEAE; HEMOLYTIC UREMIC SYNDROME; HUMAN; IRRITABLE COLON; MALARIA; MONOTHERAPY; NOROVIRUS; ORAL REHYDRATION THERAPY; PERSONAL HYGIENE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; TRAVELLER DIARRHEA; UNSPECIFIED SIDE EFFECT; VACCINATION; VAGINA CANDIDIASIS;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; COMBINED MODALITY THERAPY; DIARRHEA; DIET; FLUID THERAPY; FOODBORNE DISEASES; HUMANS; HYGIENE; TRAVEL; VACCINES; VIRUS DISEASES;

EID: 54049137211     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a1746     Document Type: Review

References (34)

1. Greenwood Z, Black J, Weld L, O'Brien D, Leder K, Von Sonnenburg F, et al. Gastrointestinal infection among international travelers globally. J Travel Med 2008;15:195-202.
2. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. Am J Trop Med Hyg 2000;62:585-9.
3. Jiang ZD, Butzler JP. The bacterial pathogens. In: Ericsson CD, DuPont HL, Steffen R, eds. Travelers' diarrhea. 2nd ed. Hamilton, Ontario: BC Decker, 2008:6-17.
4. Riddle MS, Sanders JW, Putnam SD, Tribble DR. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 2006;74:891-900.
5. Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001;32:1706-9.
6. Ekdahl K, Andersson Y. Regional risks and seasonality in travel-associated campylobacteriosis. BMC Infect Dis 2004;4:54.
7. Ko G, Garcia C, Jiang ZD, Okhuysen PC, Belkind-Gerson J, Glass RI, et al. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol 2005;43:6126-9.
8. Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg 2008;79:210-4.
9. Jiang ZD, Lowe B, Verenkar MP, Ashley D, Steffen R, Tornieporth N, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002;185:497-502.
10. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004;99:1774-8.
11. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006;43:898-901.
12. Steffen R, Collard F, Tornieporth N, Campbell-Forrester S, Ashley D, Thompson S, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA 1999;281:811-7.
13. Cartwright RY. Food and waterborne infections associated with package holidays. J Appl Microbiol 2003;94(suppl):12-24S.
14. Hill DR, Ryan ET. Diet and education about risks. In: Ericsson CD, DuPont HL, Steffen R, eds. Travelers' diarrhea. 2nd ed. Hamilton, Ontario: BC Decker, 2008:180-9.
15. Shlim DR. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea. Clin Infect Dis 2005;41(suppl 8):S531-5.
16. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis 2006;6:361-73.
17. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet 2008;371:2019-25.
18. DuPont HL, Ericsson CD, Johnson PC, Bitsura JAM, DuPont MW, de la Cabada FJ. Prevention of travelers'diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987;257:1347-50.
19. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006;6:374-82.
20. Hill DR, Ericsson CD, Pearson RD, Keystone IS, Freedman DO, Kozarsky PE, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;43:1499-539.
21. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005;142:805-12.
22. Caeiro JP, DuPont HL, Albrecht H, Ericsson CD. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea. Clin Infect Dis 1999;28:1286-9.
23. Huang DB, Awasthi M, Le BM, Leve ME, DuPont MW, DuPont HL, et al. The role of diet in the treatment of travelers' diarrhea: a pilot study. Clin Infect Dis 2004;39:468-71.
24. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977;73:715-8.
25. Johnson PC, Ericsson CD, DuPont HL, Morgan DR, Bitsura JM, Wood LV. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers' diarrhea. JAMA 1986;255:757-60.
26. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev 2000;(3):CD002242.
27. Adachi JA, Ericsson CD, Jiang ZD, DuPont MW, Martinez-Sandoval F, Knirsch C, et al. Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. Clin Infect Dis 2003;37:1165-71.
28. Tribble DR, Sanders JW, Pang LW, Mason C, Pitarangsi C, Baqar S, et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007;44:338-46.
29. DuPont HL, Jiang ZD, Ericsson CD, Adachi JA, Mathewson JJ, DuPont MW, et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001;33:1807-15.
30. Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 2006;74:1060-6.
31. Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, et al. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 2007;5:451-6.
32. Ericsson CD, DuPont HL, Okhuysen PC, Jiang ZD, DuPont MW. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone. J Travel Med 2007;14:312-9.
33. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenberg F, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006;354:119-30.
34. Norman FF, Perez-Molina J, Perez de Ayala A, Jimenez BC, Navarro M, Lopez-Velez R. Clostridium difficile-associated diarrhea after antibiotic treatment for traveler's diarrhea. Clin Infect Dis 2008;46:1060-3.